Nonsteroidal Anti-Inflammatory Drugs

Physical Medicine and Rehabilitation Clinics of North America

Volumn 17, Issue 2, 2006, Pages 347-354

  Dugowson, Carin E ^a   Gnanashanmugam, Priya ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; INDOMETACIN; LISINOPRIL; MISOPROSTOL; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; POTASSIUM SPARING DIURETIC AGENT; PROTON PUMP INHIBITOR; ROFECOXIB; SALICIN; STEROID; VALDECOXIB; WARFARIN;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ANALGESIC ACTIVITY; ANKYLOSING SPONDYLITIS; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ASTHMA; ATHEROSCLEROSIS; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; DIABETIC NEUROPATHY; DIARRHEA; DIGESTIVE SYSTEM INJURY; DIGESTIVE SYSTEM ULCER; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG SELECTIVITY; DRUG TOLERABILITY; DRUG USE; DYSPEPSIA; ELECTROLYTE DISTURBANCE; EROSION; FEVER; FIBROMYALGIA; FOOT PAIN; GASTRODUODENAL ULCER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HUMAN; HYPERKALEMIA; HYPERTENSION; INFLAMMATION; INJURY; LEG PAIN; LOW BACK PAIN; NEPHROTIC SYNDROME; NEPHROTOXICITY; NEUROPATHIC PAIN; OSTEOARTHRITIS; PAIN; PERIPHERAL EDEMA; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; RHEUMATOID ARTHRITIS; SPINAL PAIN; STOMACH EROSION; THORACOLUMBAR SPINE; THROMBOCYTOPATHY; TRAFFIC ACCIDENT; UNSPECIFIED SIDE EFFECT; UPPER GASTROINTESTINAL TRACT; VERTEBRA FRACTURE; WILLOW;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33646000611     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2005.12.012     Document Type: Review

References (28)

1. Vane J.R., and Botting R.M. The mechanism of action of aspirin. Thromb Res 110 (2003) 255-258
2. Brunton L., Lazo J., and Parker K. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. (2006), McGraw-Hill Companies, Inc, New York
3. Fitzgerald G.A. COX-2 and beyond: approaches to prostaglandin inhibition in human disease. Nat Rev Drug Discov 2 (2003) 879-890
4. Burke A., Smyth E.M., and Fitzgerald G.A. Analgesic-antipyretic agents; pharmacotherapy of gout. In: Brunton L.L., Laxo J.S., and Parker K.L. (Eds). Goodman & Gilman's the pharmacologic basis of therapeutics. 11th ed. (2006), McGraw-Hill, New York
5. In: Coltran R.S., Kumar V., and Robbins S.L. (Eds). Robbins pathologic basis of disease. 5th ed. (1994), Saunders, Philadelphia
6. Ekman E.F., and Koman L.A. Acute pain following musculoskeletal injuries and orthopaedic surgery: mechanisms and management. Instr Course Lect 54 (2005) 21-33
7. van Tulder M.W., Scholten R.J.P.M., Koes B.W., and Deyo R.A. Non-steroidal anti-inflammatory drugs for low-back pain. Cochrane Database Syst Rev 2 (2000) CD000396
8. Schnitzer T.J., Ferraro A., Hunsche E., et al. A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain. J Pain Symptom Manage 28 (2004) 72-95
9. Goldenberg D.L., Burckardt C., and Crofford L. Management of fibromyalgia syndrome. JAMA 292 (2004) 2388-2395
10. Hickey R.F. Chronic low back pain: a comparison of diflunisal with paracetamol. NZ Med J 95 (1982) 312-314
11. Videman T., and Osterman K. Double-blind parallel study of piroxicam versus indomethacin in the treatment of low back pain. Ann Clin Res 16 (1984) 156-160
12. Berry H., Bloom B., Hamilton E.B., et al. Naproxen sodium, diflunisal, and placebo in the treatment of chronic back pain. Ann Rheum Dis 41 (1982) 129-132
13. Peloso P., Gross A., Haines T., et al. Medicinal and injection therapies for mechanical neck disorders. The Cervical Overview Group. Cochrane Database Syst Rev 2 (2005) CD000319
14. Gollapudi R.R., Teirstein P.S., et al. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA 292 (2004) 3017-3023
15. Jenkins C., Costello J., and Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 328 (2004) 434-436
16. Woessner K.M., Simon R.A., and Stevenson D.D. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 93 (2004) 339-344
17. Russell M.W., and Jobes D. What should we do with aspirin, NSAIDs, and glycoprotein-receptor inhibitors?. Int Anesthesiol Clin 40 (2002) 63-76
18. Rostom A., Dube C., Wells G., et al. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev 4 (2002) CD002296
19. Wong V.W., and Chan F.K. Review: misoprostol or COX-2-specific or selective NSAIDs reduce gastrointestinal complications and symptomatic ulcers. ACP J Club 142 (2005) 75
20. Silverstein F.E., Faich G., Goldstein J.L., et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized controlled trial. JAMA 284 (2000) 1247-1255
21. Chan F.K., Hung L.C., Suen B.Y., et al. Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial. Gastroenterology 127 (2004) 1038-1043
22. Garner S.E., Fridan D.D., Frankish R.R., et al. Celecoxib for rheumatoid arthritis. Cochrane Database Syst Rev 4 (2002) CD003831
23. Battistella M., Mamdami M.M., Juurlink D.N., et al. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Arch Intern Med 165 (2005) 189-192
24. Brater D.C., Harris C., Redfern J.S., et al. Renal effects of COX-2-selective inhibitors. Am J Nephrol 21 (2001) 1-15
25. Weir M.R. Renal effects of nonselective NSAIDs and coxibs. Cleve Clin J Med 69 Suppl 1 (2002) SI53-SI58
26. Krotz F., Schiele T.M., Klauss V., et al. Selective COX-2 inhibitors and risk of myocardial infarction. J Vasc Res 42 (2005) 312-324
27. Namaka M., Gramlich C.R., Ruhlen D., et al. A treatment algorithm for neuropathic pain. Clin Ther 26 (2004) 951-979
28. Raffa R.B., Clark-Vetri R., Tallarida R.J., et al. Combination strategies for pain management. Expert Opin Pharmacother 4 (2003) 1697-1708